A 38-year-old HIV-infected man with a CD4+ cell count of 4/µL and an HIV RNA level of more than 750,000 copies/mL was admitted to the hospital after 1 month of painful right neck swelling and 1 week of dysphagia.
Almost 2 years ago I reviewed the topic of hepatitis C virus (HCV) infection in the setting of HIV.1 Given the advances–and some setbacks–in our understanding of HCV pathogenesis and treatment in the coinfected population, it's time for an update.
Both HIV and its treatment, particularly protease inhibitors, can cause dyslipidemia similar to that seen with the metabolic syndrome. The most notable effects are elevated triglyceride levels and decreased high-density lipoprotein cholesterol levels, with or without elevated low-density lipoprotein cholesterol (LDL-C) levels.
Pain is recognized as a significant disability in HIV-infected persons.
CD4 Count Improvement Following Tenofovir to Abacavir Switch in a Patient With Persistent Lymphopenia Despite an Undetectable Viral Load
Many different antiretroviral regimens can be used as initial therapy for infection with HIV.
Since the introduction of highly active retroviral therapy and with the improvement in the survival of persons with HIV/AIDS, the spectrum of renal disease in HIV-infected persons has expanded.
Because widespread use of highly active antiretroviral therapy has made it possible for persons with HIV infection to live longer, the epidemiology of HIV/AIDS has shifted in several ways
Government Cancels Testing of HIV Vaccine, Roche to Suspend HIV Research, New TB Drug Resistance Test, Topical Estrogen Protects Men
On Thursday, July 17, plans to conduct a large-scale test of an experimental therapeutic AIDS vaccine were canceled, the latest setback following last year’s failed Merck AIDS vaccine trial (Russell S. San Francisco Chronicle. July 18, 2008).
In recent years, few breakthroughs in HIV prevention science have been realized. Preexposure prophylaxis (PrEP), involving the use of antiretrovirals just before a potentially risky sexual encounter, is an intriguing concept, although it’s not new.
The words HIV or AIDS do not appear in the title of this book, and at first glance, this book appears to be about something else. On the contrary, it is about HIV and much more.
The prevalence of Kaposi sarcoma (KS) in HIV-infected persons in the pre-HAART era has been reported to be as high as 20%. Although AIDS-associated KS has declined by more than 80% since the introduction of highly active antiretroviral regimens, KS remains an important malignancy in the HIV-infected population
HIV-Associated Nemaline Rod Myopathy: Role of Intravenous Immunoglobulin Therapy in Two Persons With HIV/AIDS
Nemaline rod myopathy is a rare human neuromuscular disorder defined by the presence of rod-shaped structures infiltrating muscle fibers.
A program that is gaining interest and momentum in some health care circles is so-called academic detailin
A 52-year-old woman presented with a 2-year history of progressive bilateral lower extremity edema and increasing pain. The patient complained of shortness of breath, productive cough, and rash on the upper extremities and torso for the past year.
Legionella species are among the leading causes of community-acquired pneumonia (CAP) in the general population, and although rare in patients with HIV infection, Legionella pneumonia is associated with significant morbidity and mortality